Great partnerships start with a conversation.

Yes. Our team is ABPI certified, and we regularly navigate international regulatory codes (including EFPIA and FDA guidelines). We build compliance into the creative process from day one, ensuring your assets navigate MLR review smoothly without losing strategic impact.

We enforce enterprise-grade security protocols—including end-to-end encryption, granular access permissions, two-factor authentication, and strict NDA compliance—ensuring unreleased clinical trial data and brand IP remain fully secure.

We support healthtech scale-ups, life science innovators, and global pharma divisions across UK, European, and US markets.

Our Creative Sprints condense traditional agency timelines into focused two-week execution blocks. We deploy a dedicated senior studio unit exclusively on your brief—running from kickoff and research through concepting, rapid prototyping, and final compliance-ready delivery with high velocity.

Typical Touchpoints:

Kickoff & Alignment: Clarify clinical objectives, audience targets, and regulatory boundaries.

‍Discovery & Strategy: Uncover insights and define the core creative direction.

‍Concept & Prototype: Build initial high-fidelity concepts and interactive wireframes.

‍Refinement & Delivery: Polish visual assets for MLR review and rapid deployment.

No. While we are digital-native, we deliver integrated healthcare communications across all channels—from interactive digital detailers, congress installations, and web applications to core brand identity, print collateral, and multi-channel campaign creative.

Autonomous Health operates as a senior healthcare studio rather than a traditional agency. We eliminate junior hand-offs, heavy account management layers, and retainer bloat—giving client teams direct access to senior leads who write, design, and build work hands-on.

A Senior Healthcare Studio is an agile, specialized communications unit led entirely by seasoned healthcare strategists, medical writers, and creative directors. It provides enterprise-level precision and compliance-ready output without the high overhead or slow turnaround times of traditional agencies.

We integrate regulatory and clinical context directly into the initial brief rather than treating compliance as an afterthought. By working within regulatory guardrails from concept to execution, our creative assets maintain their strategic impact while clearing MLR review efficiently.

Because we operate without middle-management layers, we onboard new briefs in days. Through our structured two-week Creative Sprints and Fast Track execution models, we deliver high-standard creative assets in a fraction of the time required by legacy agency workflows.